Page last updated: 2024-09-05

symmetric dimethylarginine and Intermittent Claudication

symmetric dimethylarginine has been researched along with Intermittent Claudication in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ajjan, R; Anderssohn, M; Böger, RH; Grant, PJ; Lüneburg, N; McLachlan, S; Price, JF; Robertson, C; Schwedhelm, E; Strachan, MW; Williamson, RM	1
Al-Shaheen, A; Brittenden, J; Rajagopalan, S; Staniszewska, A; Thies, F	1
Guntani, A; Honma, K; Itoh, H; Iwasa, K; Kyuragi, R; Maehara, Y; Matsumoto, T; Ohmine, T; Onohara, T	1

Trials

1 trial(s) available for symmetric dimethylarginine and Intermittent Claudication

Article	Year
The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans. International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:2 Suppl Topics: Administration, Oral; Aged; Ankle Brachial Index; Arginine; Arteriosclerosis Obliterans; Biomarkers; Endothelin-1; Epoprostenol; Exercise Test; Exercise Tolerance; Humans; Intermittent Claudication; Platelet Aggregation Inhibitors; Prospective Studies; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents; Walking	2010

Article

Year

The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.

International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:2 Suppl

Topics: Administration, Oral; Aged; Ankle Brachial Index; Arginine; Arteriosclerosis Obliterans; Biomarkers; Endothelin-1; Epoprostenol; Exercise Test; Exercise Tolerance; Humans; Intermittent Claudication; Platelet Aggregation Inhibitors; Prospective Studies; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents; Walking

2010

Other Studies

2 other study(ies) available for symmetric dimethylarginine and Intermittent Claudication

Article	Year
Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes. Diabetes care, 2014, Volume: 37, Issue:3 Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Environment; Female; Genotype; Humans; Intermittent Claudication; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors	2014
Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease. Journal of vascular surgery, 2015, Volume: 61, Issue:5 Topics: Aged; Ankle Brachial Index; Arginine; Arterial Occlusive Diseases; Biomarkers; Cause of Death; Female; Follow-Up Studies; Humans; Intermittent Claudication; Ischemia; Male; Middle Aged; Predictive Value of Tests	2015

Article

Year

Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.

Diabetes care, 2014, Volume: 37, Issue:3

Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Environment; Female; Genotype; Humans; Intermittent Claudication; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors

2014

Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease.

Journal of vascular surgery, 2015, Volume: 61, Issue:5

Topics: Aged; Ankle Brachial Index; Arginine; Arterial Occlusive Diseases; Biomarkers; Cause of Death; Female; Follow-Up Studies; Humans; Intermittent Claudication; Ischemia; Male; Middle Aged; Predictive Value of Tests

2015